isothiazole derivatives (Immune Pharmaceuticals/N. D. Zelinsky Institute of Organic Chemistry/Moscow Institute of Physics and Technology)
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug Nameisothiazole derivatives (Immune Pharmaceuticals/N. D. Zelinsky Institute of Organic Chemistry/Moscow Institute of Physics and Technology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesImmune Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesInstitut Organicheskoi Khimii im ND ZelinskogoThe Moscow Institute of Physics and TechnologyImmune Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A